X. Zhang, Zhijun Wang, Ying Huang
Apr 1, 2011
Citations
2
Influential Citations
52
Citations
Quality indicators
Journal
Diabetes
Abstract
Aim: Alogliptin is a potent and highly selective dipeptidyl peptidase‐4 (DPP‐4) inhibitor. The aim of this study was to determine its effects on glucose control and pancreas islet function and to identify the underlying molecular mechanisms after chronic administration, in a non‐genetic mouse model of type 2 diabetes.